Your session is about to expire
← Back to Search
Ertapenem + Zidebactam for Bacterial Infection
Study Summary
This trial is assessing the safety and tolerability of a combination of two medicines and their individual doses in healthy adults.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- You have a history of epilepsy or seizures, except for the ones caused by high fever during childhood.You need to use a condom with spermicide as a form of birth control.You have been drinking large amounts of alcohol frequently in the past 6 months.Binge drinking means having 5 or more drinks at once if you're a guy, or 4 or more drinks if you're a girl.You have severe allergies that have been causing symptoms for more than a week and require frequent use of medication to manage them.Drinking too much alcohol means having more than 15 units per week if you're a man, or more than 8 units per week if you're a woman.You cannot use nicotine products like cigarettes, e-cigarettes, pipes, cigars, chewing tobacco, or nicotine patches.If you have a long-term health condition like kidney failure or any other ongoing health problem that could make you more at risk or affect the study results, you cannot participate.
- Group 1: Cohort 1
- Group 2: Cohort 2
- Group 3: Cohort 3
- Group 4: Cohort 4
- Group 5: Cohort 5
- Group 6: Cohort 6
- Group 7: Cohort 7
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is eligibility for this clinical trial restricted to a certain age group?
"The lower limit of eligibility for this research is 18 years old while the upper boundary resides at 45."
What risks do participants in Cohort 5 face?
"There is a lack of evidence to support Cohort 5's safety and efficacy, leading our team at Power to rate it as a 1 on the risk scale."
Has recruitment for this clinical trial already begun?
"As indicated on clinicaltrials.gov, this trial is no longer searching for new patients to participate in the study. The medical research was first posted on December 12th 2022 and had its last update 15 days later. Fortunately, there are presently 64 other trials that are actively recruiting candidates at present time."
What are the criteria for eligibility in this investigation?
"This trial is open to adults aged 18-45 who have bacterial infections. They must also be in good general health, possess suitable veins for cannulation or venipuncture, and meet a variety of other requirements listed on FDA Form 1572. Non-pregnant women participants are expected to use an effective method of contraception from screening until 30 days after the last dose of medication is administered."
Share this study with friends
Copy Link
Messenger